JD HEALTH INTL LTD (8ZN) — Cash Flow Reinvestment Rate

Latest as of June 2023: 19.73x

JD HEALTH INTL LTD (8ZN) has a Cash Flow Reinvestment Rate of 19.73x as of June 2023, reinvesting €3.63 Billion (capex €19.75 Million plus investments €-3.61 Billion) from operating cash flow of €184.04 Million. See 8ZN cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

19.73x
(Capex + Investments) / Operating CF

Total Reinvested

€3.63 Billion
Capex + Investments

Operating Cash Flow

€184.04 Million
EUR

Capital Expenditures

€19.75 Million
EUR

JD HEALTH INTL LTD Cash Flow Reinvestment Rate (2019–2025)

Historical reinvestment intensity for JD HEALTH INTL LTD across 7 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of JD HEALTH INTL LTD.

Annual Cash Flow Reinvestment Rate for JD HEALTH INTL LTD (2019–2025)

Year-by-year capital reinvestment analysis for JD HEALTH INTL LTD. See JD HEALTH INTL LTD financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2025 0.06x €615.57 Million €10.17 Billion €151.01 Million ▼ -92.0%
2024 0.75x €3.26 Billion €4.33 Billion €46.35 Million ▼ -56.9%
2023 1.75x €8.04 Billion €4.60 Billion €69.33 Million ▲ +416.2%
2022 0.34x €2.00 Billion €5.91 Billion €40.16 Million ▼ -93.5%
2021 5.17x €17.75 Billion €3.43 Billion €502.21 Million ▲ +152.7%
2020 2.05x €7.57 Billion €3.70 Billion €15.70 Million ▼ -42.0%
2019 3.53x €1.45 Billion €409.47 Million €5.19 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow